🍄 Bright Minds Bio is a psychedelics research company focused on novel  psychedelics with shorter trip times and lower risk than traditional  psychedelics.  In this episode of The Integration Conversation, we  discuss the risk of traditional psychedelics, what a 5HT2C agonist is,  Bright Mind's NASDAQ Uplisting, and discuss why Bright Minds might be  undervalued relative to its peers.     ⭐️ Become an Integration Insider and get early access to episodes: https://patreon.com/theintegrationco  🎧 Listen on Spotify and other podcast platforms:  https://anchor.fm/theintegrationco  🐦 brom on twitter:  https://twitter.com/therealbrom  🎇 Clips and other stuff on Instagram:  https://instagram.com/theintegrationco  💌 Email:   [email protected]   ⏰ Timestamps:   Disclaimer: This video is not financial advice. Brom holds shares in Bright Minds.